Fidelity National Financial just reported its Q1 2026 numbers, and the result was a clean miss on both counts: adjusted EPS of $0.93 against a $1.09 estimate, and revenue of $3.23B versus a $3.61B consensus. The stock had already given back nearly 3% on the week coming into the print, and the miss hands short sellers a narrative they have been building toward for the past month.
The short-side story has quietly become one of the more interesting things about FNF heading into this event. Short interest climbed 1.3% over the past week and is now 31.7% higher than a month ago, bringing the float short to roughly 3.1%. That level — while not extreme in absolute terms — represents a meaningful change in positioning. The jump from around 6.5 million shares short in early April to 8.4 million shares by late April shows a deliberate accumulation, not noise. Despite the build, availability in the borrow market remains very loose, with cost to borrow falling sharply to just 0.27% — roughly half where it stood a month ago. That says the lending pool is not stressed: shorts are building, but they are doing so at negligible cost and without squeezing the available supply.
Options positioning has eased considerably from the extremes that characterised late March and early April. The put/call ratio in mid-to-late March reached nearly 6.9 — a 52-week high — before collapsing to the current 1.81, now running below its 20-day average of 3.1. The z-score of -0.89 confirms this is a lighter-than-usual defensive posture relative to recent history. In plain terms: the options market was braced for something bad, and as the earnings date approached, some of that protection was unwound. The question now is whether the miss prompts a fresh round of put buying.
The Street was cautious before the print, and the recent analyst moves reinforce that read. Keefe Bruyette & Woods held an Outperform but trimmed its target from $71 to $67 in early April. Barclays, sitting at Equal-Weight, cut from $63 to $54 around the same time. Together, both moves signal that the sell-side has been recalibrating lower without fully abandoning the bull case. At $51.18, the stock still sits at a significant discount to the consensus mean target of $64.60 — implying roughly 26% upside at face value. But that target pre-dates the Q1 miss, and revisions are likely incoming. On valuation, the trailing P/E of 8.4x and an EV/EBITDA around 4.8x keep FNF in inexpensive territory relative to the broader market; the forward EPS growth score (85th percentile) suggested the earnings trajectory was supportive — before tonight.
The two most recent earnings reactions are instructive for context. After the February 2026 results, the stock fell 5.9% the next day and extended to -7.0% over five sessions. The pattern from the prior quarter was even worse: a 7.0% drop on the day, compounding to -6.9% over the week. If the Q1 miss — particularly the $380M revenue shortfall — triggers a similar response, the recent 12% one-month gain could be quickly eroded. Closest peer FAF fell 3.0% on the week, while STC dropped 3.8%, suggesting the title insurance group broadly faced headwinds even before FNF's own print arrived.
BlackRock added 1.8 million shares as recently as April 30 — now the largest holder at 11.7% — while Vanguard made only marginal adjustments. The WindAcre Partnership held an unchanged 7.3% stake as of year-end. With institutional ownership concentrated and a fresh earnings miss in the market after hours, how those holders respond to any near-term weakness is the key variable to monitor over the next two sessions.
See the live data behind this article on ORTEX.
Open FNF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
